Moderna

News

Merck, Moderna cue up phase 3 trials for mRNA cancer shot

Moderna and partner Merck & Co have fleshed out the data from their clinical trial of personalised mRNA vaccine for melanoma, saying the results support the start of a

News

Moderna’s flu vaccine trial delayed by case numbers

Moderna’s aspiration to become a player in the seasonal influenza vaccine market has hit a hurdle – likely a delay rather than anything more serious – but its stock has st

News

J&J decides not to play catch-up in RSV vaccination

Johnson & Johnson has decided to bow out of the market for respiratory syncytial virus (RSV) vaccines, abandoning a late-stage development programme that would have be

News

Moderna picks Oxfordshire for UK facility

Moderna selects Harwell in Oxfordshire for its new UK facility, next door to the UKHSA.

Oncology

Could cancer be the next mRNA breakthrough?

mRNA vaccines achieved their first success against COVID-19, but could a cancer target be next?

Patients

How Moderna kept diversity in mind amid vaccine development

In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.

Merck, Moderna cue up phase 3 trials for mRNA cancer shot

Moderna’s flu vaccine trial delayed by case numbers

J&J decides not to play catch-up in RSV vaccination

Moderna picks Oxfordshire for UK facility

Could cancer be the next mRNA breakthrough?

How Moderna kept diversity in mind amid vaccine development

Lilly's 'triple G' retatrutide aces crucial obesity trial

Discover a new era of healthcare panel engagement: Grounded ...

Moderna

Editor's Picks